Dan Leonard, longtime leader of the National Pharmaceutical Council who became CEO of the Association for Accessible Medicines in September, discusses the impact of generic medications on health care, and the challenges and opportunities facing the industry. Among the issues addressed are generics’ role in treating COVID-19 patients, the emergence of biosimilars, and the Medicaid generics penalty.
Video Forum: Dan Leonard, AAM
Latest
WBA shareholders overwhelmingly approve acquisition by Sycamore Partners
Ninety-six percent of shareholders and 95% of unaffiliated shareholders at a special meeting voted in favor of the deal.c
Retail sales dip in June amid consumer uncertainty, NRF reports
Tariff concerns and economic unease drive first monthly sales decline since February.
As prices rise, moms take lead family spending decisions
The study revealed that rising costs and an overload of choices are the primary stressors for mothers.
Mall Traffic eases in June following spring surge
Indoor malls continued to demonstrate the strongest performance among shopping formats.